Financial News · Live Terminal

Page 40 of 519

Loop Capital Initiates SoFi Technologies at Hold With $22 Price Target

SoFi Technologies Inc (SOFI) has an average rating of hold and mean price target of $20.14, according to analysts polled by FactSet.

$SOFI

Research15d ago

Loop Capital Initiates Chime Financial at Buy With $45 Price Target

Chime Financial, Inc. Class A (CHYM) has an average rating of buy and mean price target of $37.91, according to analysts polled by FactSet.

$CHYM

Research15d ago

Piper Sandler Initiates X-Energy at Underweight With $9 Price Target

X-Energy (XE) has an average rating of overweight and mean price target of $34.38, according to analysts polled by FactSet.

$XE

Research15d ago

Piper Sandler Initiates Oklo at Overweight

Oklo (OKLO) has an average rating of overweight and mean price target of $75.03, according to analysts polled by FactSet.

$OKLO

Research15d ago

Piper Sandler Initiates Argan at Underweight

Argan (AGX) has an average rating of overweight and mean price target of $573, according to analysts polled by FactSet.

$AGX

Research15d ago

Leerink Partners Initiates Coverage on Bausch Health With Outperform Rating, $24 Price Target

$BHC

Research15d ago

Leerink Partners Initiates Coverage on Collegium Pharmaceutical With Outperform Rating, $45 Price Target

Collegium Pharmaceutical (COLL) has an average rating of buy and mean price target of $48.86, according to analysts polled by FactSet.

$COLL

Research15d ago

Leerink Partners Initiates Coverage on Harrow With Outperform Rating, $45 Price Target

Harrow (HROW) has an average rating of buy and mean price target of $68.38, according to analysts polled by FactSet.

$HROW

Research15d ago

Leerink Partners Initiates Coverage on Amneal Pharmaceuticals With Outperform, $23 Price Target

Amneal Pharmaceuticals (AMRX) has an average rating of overweight and mean price target of $20.75, according to analysts polled by FactSet.

$AMRX

Research15d ago

B. Riley Initiates Better Home & Finance at Buy With $26 Price Target

Better Home & Finance (BETR) has an average rating of overweight and mean price target of $25.67, according to analysts polled by FactSet.

$BETR

Research15d ago

Leerink Partners Initiates Coverage on Pacira Biosciences With Market Perform Rating, $28 Price Target

Pacira Biosciences (PCRX) has an average rating of overweight and mean price target of $30, according to analysts polled by FactSet.

$PCRX

Research15d ago

Leerink Partners Initiates Coverage on Nautilus Biotechnolgy With Outperform Rating, $4 Price Target

$NAUT

Research15d ago

Jefferies Upgrades UGI to Buy From Hold, Adjusts Price Target to $43 From $40

$UGI

Research15d ago

Leerink Partners Initiates Coverage on Teva Pharmaceutical Industries With Outperform Rating, $45 Price Target

Teva Pharmaceutical Industries (TEVA) has an average rating of buy and mean price target of $41.89 according to analysts polled by FactSet.

$TEVA

Research15d ago

Jefferies Upgrades Summit Therapeutics to Buy From Hold, Adjusts Price Target to $25 From $15

Summit Therapeutics Inc (SMMT) has an average rating of overweight and mean price target of $29.06, according to analysts polled by FactSet.

$SMMT

Research15d ago

Leerink Partners Initiates Coverage on Phathom Pharmaceuticals With Market Perform, $10 PT

Phathom Pharmaceuticals (PHAT) has an average rating of Buy and mean price target of $23.70, according to analysts polled by FactSet.

$PHAT

Research15d ago

Barclays Upgrades Sagimet Biosciences to Overweight From Equalweight, Adjusts Price Target to $18 From $8

Sagimet Biosciences (SGMT) has an average rating of buy and mean price target of $29.33, according to analysts polled by FactSet.

$SGMT

Research15d ago

BMO Capital Downgrades Westlake to Market Perform From Outperform, Adjusts Price Target to $82 From $96

Westlake (WLK) has an average rating of overweight and mean price target of $93.88, according to analysts polled by FactSet.

$WLK

Research15d ago

Morgan Stanley Upgrades Lineage to Overweight From Equalweight

Lineage (LINE) has an average rating of hold and mean price target of $45.67, according to analysts polled by FactSet.

$LINE

Research15d ago

BofA Securities Downgrades Patria Investments to Underperform From Neutral, $10 Price Target

Patria Investments (PAX) has an average rating of overweight and mean price target of $16.86, according to analysts polled by FactSet.

$PAX

Showing 781-800 of 10370